U.S. Medical Equipment Stock News

NYSE:AEM
NYSE:AEMMetals and Mining

Agnico Eagle Mines (AEM) Earnings Jump Following Buyback But Is The Valuation Case Priced In

Agnico Eagle Mines (AEM) is back in focus after reporting higher net income and earnings per share for the second quarter and first half of 2026, along with a confirmed dividend and completed share buyback. See our latest analysis for Agnico Eagle Mines. The improved earnings, dividend affirmation and completed buyback come as Agnico Eagle Mines trades at US$167.92, with a 7 day share price return of 11.39% and a 1 year total shareholder return of 24.83%, while the 3 year total shareholder...
NYSE:RRX
NYSE:RRXElectrical

Regal Rexnord (RRX) Earnings Beat Puts Valuation Back In Focus

Regal Rexnord (RRX) is back in focus after its latest quarterly update, which combined an earnings beat, firmer margins from merger synergies and operations, and a narrower earnings outlook for 2026. See our latest analysis for Regal Rexnord. Despite the strong second quarter update, Regal Rexnord’s recent share price performance has cooled, with the stock down 11.63% over seven days and 16.49% over ninety days. This comes even as the year-to-date share price return of 22.53% and 1-year total...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Analog Devices (ADI) Could Be 16% Undervalued After Analyst Optimism Ahead Of Earnings

Recent analyst optimism and higher earnings estimates have pushed Analog Devices (ADI) into focus ahead of its upcoming quarterly report, as investors weigh this earnings momentum against ongoing concerns around competition and margins. See our latest analysis for Analog Devices. At a share price of $377.31, Analog Devices has seen its 1-year total shareholder return of 71.38% far outpace its recent 90-day share price decline of 9.41%, so momentum has cooled after a strong run year to...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Is Ionis Pharmaceuticals (IONS) Cheap On Its Earnings Miss And CSO Retirement?

Ionis Pharmaceuticals (IONS) is back in focus after its latest quarterly report showed revenue of US$267.95 million and a swing from a prior profit to a net loss of US$114.65 million. See our latest analysis for Ionis Pharmaceuticals. The recent earnings miss and guidance update appear to have shifted sentiment, with Ionis Pharmaceuticals’ share price down 36.88% over the past month and 31.61% year to date, even though the 1 year total shareholder return is 32.74%. This points to fading short...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

Is RadNet’s (RDNT) Digital Push Quietly Redefining Its Earnings Power?

RadNet recently approached its latest earnings release with analysts expecting quarterly earnings of US$0.18 per share, below the prior year, but forecasting year-over-year revenue growth driven by its Imaging Centers and Digital Health segments. This combination of softer earnings and stronger revenue expectations has drawn attention to how RadNet’s growing digital and imaging operations could be reshaping its business mix and performance drivers. Now we’ll examine how anticipated revenue...
NYSE:NET
NYSE:NETIT

Why Is Cloudflare (NET) Expanding Into AI Visibility, Workspaces And Governance?

Cloudflare (NYSE: NET) has introduced a new set of AI products, including the AEO Visibility Dashboard, Cloudflare OS, and an Identity-Aware AI Gateway. The AEO Visibility Dashboard is designed to help brands track how they appear across AI generated content and responses. Cloudflare OS is positioned as an open source AI workspace for enterprises, while the Identity-Aware AI Gateway targets oversight of employee AI usage and access. These launches expand Cloudflare's role in AI...
NasdaqGS:DDOG
NasdaqGS:DDOGSoftware

Datadog (DDOG) Stock May Be 22% Undervalued After Log Coverage Launch

After a strong three year gain for Datadog stock, the valuation picture is split. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside, while market multiples suggest the shares trade at a richer level. Datadog has returned 152.7% over the past three years, which puts extra focus on whether today's price still leaves enough potential reward for the risk. The recent Cloudaware LogSight partnership can support the case for ongoing demand for Datadog's...
NYSE:MTZ
NYSE:MTZConstruction

Is MasTec (MTZ) Undervalued On Strong Earnings And 2026 Guidance?

Why MasTec’s latest earnings and guidance matter for stock investors MasTec (MTZ) recently posted higher second quarter and half year sales and net income compared with a year earlier. The company also issued guidance that points to higher revenue and GAAP earnings for 2026. For the second quarter ended June 30, 2026, MasTec reported sales of US$4,373.55 million compared with US$3,544.71 million a year earlier. Net income was US$130.12 million compared with US$85.77 million for the prior year...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Is Nebius Group (NasdaqGS:NBIS) Priced For Perfection After A 191% Run?

Nebius Group stock has surged over the past year, yet the current valuation checks suggest the shares do not screen as a clear bargain on most metrics. For investors watching a fast moving AI infrastructure story, the key question is how much of that enthusiasm is already reflected in today’s price. Over the last 12 months, Nebius Group has returned 190.7%, which puts a spotlight on whether recent gains already factor in much of the expected growth. Expectations around Nebius Group’s role in...